119 related articles for article (PubMed ID: 37782060)
1. Prognostic value of indoleamine 2, 3-dioxygenase-1 expression in glial tumors.
Kaya M; Aksoy A; Artas G; Kaplan M
Ideggyogy Sz; 2023 Sep; 76(9-10):339-347. PubMed ID: 37782060
[TBL] [Abstract][Full Text] [Related]
2. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
[TBL] [Abstract][Full Text] [Related]
3. Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors.
Batista CE; Juhász C; Muzik O; Kupsky WJ; Barger G; Chugani HT; Mittal S; Sood S; Chakraborty PK; Chugani DC
Mol Imaging Biol; 2009; 11(6):460-6. PubMed ID: 19434461
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma.
Urakawa H; Nishida Y; Nakashima H; Shimoyama Y; Nakamura S; Ishiguro N
Clin Exp Metastasis; 2009; 26(8):1005-12. PubMed ID: 19802733
[TBL] [Abstract][Full Text] [Related]
6. The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma.
Seppälä M; Halme E; Tiilikainen L; Luukkainen A; Laranne J; Rautiainen M; Huhtala H; Paavonen T; Toppila-Salmi S
Acta Otolaryngol; 2016 Jul; 136(7):729-35. PubMed ID: 26982018
[TBL] [Abstract][Full Text] [Related]
7. Prognosis significance of indoleamine 2, 3-dioxygenase, programmed death ligand-1 and tumor-infiltrating immune cells in microenvironment of breast cancer.
Wei L; Wu N; Wei F; Li F; Zhang Y; Liu J; Ren X
Int Immunopharmacol; 2020 Jul; 84():106506. PubMed ID: 32330866
[TBL] [Abstract][Full Text] [Related]
8. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
[TBL] [Abstract][Full Text] [Related]
9. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
Front Immunol; 2018; 9():724. PubMed ID: 29719533
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis.
Wang S; Wu J; Shen H; Wang J
BMC Cancer; 2020 May; 20(1):471. PubMed ID: 32456621
[TBL] [Abstract][Full Text] [Related]
11. High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients.
Asghar K; Rana IA; Abubakar M; Hasham K; Tahseen M; Bilal S; Mehmood S; Farooq A; Siddique K; Loya A
Asian Pac J Cancer Prev; 2023 May; 24(5):1591-1600. PubMed ID: 37247278
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
13. Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients.
Jia Y; Wang H; Wang Y; Wang T; Wang M; Ma M; Duan Y; Meng X; Liu L
Int J Cancer; 2015 Sep; 137(5):1095-106. PubMed ID: 25683635
[TBL] [Abstract][Full Text] [Related]
14. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
Zhao Y; Wei L; Liu J; Li F
Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine-pyrrole 2,3-dioxygenase might be a prognostic biomarker for patients with renal cell carcinoma.
Yuan F; Liu Y; Fu X; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):649-55. PubMed ID: 22886215
[TBL] [Abstract][Full Text] [Related]
17. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
18. Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas.
Hudolin T; Mengus C; Coulot J; Kastelan Z; El-Saleh A; Spagnoli GC
Anticancer Res; 2017 Mar; 37(3):1375-1380. PubMed ID: 28314306
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the expressions of indoleamine 2, 3-dioxygenase in hepatocellular carcinoma and clinicopathological parameters].
Lin L; Yang DH; Huang Y; Li XH; Zhang QL; Liu X; Liang JK; Zhong KB; He H
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2186-90. PubMed ID: 24169325
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation.
Miyazaki T; Moritake K; Yamada K; Hara N; Osago H; Shibata T; Akiyama Y; Tsuchiya M
J Neurosurg; 2009 Aug; 111(2):230-7. PubMed ID: 19199463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
